semaglutide anaesthesia regional anaesthesia - Oralsemaglutideand anesthesia anaesthesia Navigating the Anesthesia Landscape with Semaglutide: Safety and Expert Guidance

Semaglutideand dental anesthesia The increasing popularity of semaglutide for weight management and diabetes treatment presents new considerations for anesthesia providers. A critical aspect of the perioperative considerations for patients on semaglutide involves understanding its impact on gastric emptying and the potential for anesthesia-related complications.CAS Medication Safety Bulletin While beneficial for many, semaglutide and other GLP-1 receptor agonists can lead to delayed gastric emptying and residual gastric contents, posing a significant risk of pulmonary aspiration during procedures. This article delves into the emerging anesthesia risks associated with semaglutide, supported by expert opinion and clinical findings, to ensure patient safety.Perioperative management of patients taking glucagon-like ...

One of the primary concerns highlighted in peer-reviewed literature is the potential for regurgitation under anesthesia in a fasted patient prescribed semaglutide. Studies, such as those published in the *Canadian Journal of Anaesthesia*, have documented cases where patients on semaglutide presented with substantial gastric volumes despite adhering to standard preoperative fasting guidelinesPerioperative Considerations for Patients on Semaglutide. This phenomenon is directly linked to semaglutide's mechanism of action, which includes slowing down the rate at which the stomach empties its contents.2023年9月27日—The semaglutide dose had been increased approximately 2 weeks before the surgery, with the last dose given 7 days before surgery. The consequence of this delayed gastric emptying is an increased likelihood of undigested food or liquid remaining in the stomach, elevating the risk of aspiration into the lungs during induction of anesthesia, particularly general anaesthesia.2023年6月29日—The GLP-1 agonists are associated with adverse gastrointestinal effects such as nausea, vomiting and delayed gastric emptying.

The risk of pulmonary aspiration during semaglutide use and anesthesia is a serious concern that necessitates careful preoperative assessment. Anesthesiologists are advised to specifically inquire about semaglutide and other GLP-1 agonists during their preoperative evaluations. This proactive approach, as recommended by organizations like the American Society of Anesthesiologists, ensures that potential risks are identified early. The consensus among many experts is that patients taking semaglutide or similar medications should withhold the medication for a week prior to anaesthesia, or at a minimum, for a period aligned with the drug's half-life. Given semaglutide's approximate one-week half-life, a washout period of about five weeks is needed to reach a steady state, making a longer cessation period potentially more prudent for some individuals.

However, the discussion around the optimal timing for stopping semaglutide before surgery is evolving. While some studies and guidelines have suggested stopping the medication for at least 7 days, recent clinical guidance indicates that most patients can continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery. This nuanced approach aims to balance the benefits of continuing therapy against the potential risks.作者：LL Fortis-Olmedo·2025·被引用次数：1—This study discusses the case of a patient on weeklysemaglutidetreatment scheduled for elective surgery, with 12 hours of preoperative fasting ... It is crucial for patients to discuss their medication regimen with their surgeon and anaesthetist well in advance of their planned procedureElective peri‐operative management of adults taking glucagon ....

For patients undergoing procedures requiring anesthesia, alternative strategies can mitigate risks.Anesthesia Considerations for a Patient on Semaglutide ... These include the use of regional anaesthesia, which may bypass some of the risks associated with general anesthesia, and tracheal intubation to secure the airway. Modified rapid sequence induction techniques are also considered. The presence of gastrointestinal symptoms such as severe nausea, vomiting, bloating, or abdominal pain on the day of the procedure, even after discontinuing the medication, should be a red flag for the anaesthetist.

The medical community is actively researching and refining best practices for semaglutide anesthesia management. Areas of ongoing investigation include the impact of oral semaglutide and anesthesia, and the considerations for semaglutide and local anesthesia. Understanding the interplay between these medications and various anesthetic techniques is vital for patient safety作者：SL Pai·2024·被引用次数：12—Recent Findings: Sincesemaglutide may cause delayed gastric emptying and residual gastric contents, controversies arise on preoperative medication management, .... While the risks are real, a collaborative approach between the patient, the prescribing physician, and the anesthesia team can ensure that procedures involving individuals on semaglutide are conducted safely and effectively, minimizing the chance of adverse events like regurgitation under anesthesia.2025年1月9日—Regurgitation under anesthesia in a fasted patient prescribed semaglutidefor weight loss: a case report. Can J Anesth 2023; 70: 1397–400. https ... The focus remains on individual patient assessment and adapting anesthetic management to account for the known effects of GLP-1 receptor agonists.